+
+
Stay Informed
STRUCTURAL INTERVENTIONS

AMPLATZER™ AMULET™ LAA OCCLUDER CLINICAL DATA

Designed to treat patients with non-valvular atrial fibrillation (AF) who are at risk of ischemic stroke, the Amplatzer Amulet LAA Occluder offers complete closure of the left atrial appendage (LAA) and immediately eliminates the need for oral anticoagulants.1

STROKE RISK REDUCTION, AND FREEDOM FROM ANTICOAGULANTS

Clinical studies have shown that implanting AFib patients with the Amplatzer Amulet occluder is a safe and effective treatment option to reduce their risk of stroke and eliminate the need for oral anticoagulants.

99%

SUCCESS
RATE2

99%

effective
closure1

79%

left the hospital without using OACs1

67%

reduction in stroke risk2

CLICK THE LINKS BELOW TO LEARN MORE
ABOUT AMULET OCCLUDER DATA

 

THE AMULET OCCLUDER IS PROVEN TO PROVIDE SUPERIOR COMPLETE CLOSURE1

Head-To-Head study demonstrates 63% lower risk of moderate or greater leaks with Amulet occluder3

Amulet occluder patients had significantly higher complete LAA closure rate by TEE compared to Watchman‡ device at both 45 days and 12 months.

‡Indicates a third party trademark, which is property of its respective owner.

Abbott Amplatzer Portfolio App helps physicians determine which structural intervention device to use

NEW VERSION AVAILABLE
GET THE AMPLATZER PORTFOLIO APP

The Amplatzer Portfolio App helps physicians determine which Amplatzer Structural Interventions device to use by suggesting applicable devices based on respective Instructions for Use.
 

App Store
Google Play

MAT-2201604 v3.0 | Item approved for OUS use only.

References
  1. Lakkireddy et al. Amplatzer Amulet Left Atrial Appendage Occluder versus Watchman Device for Stroke Prophylaxis (Amulet IDE). Circulation. 2021.
  2. Hildick-Smith D, Landmesser U, Camm AJ, et al. Left atrial appendage occlusion with the Amplatzer™ Amulet™ device: full results of the prospective global observational study. European Heart Journal. 2020.
  3. Ellis et al. HRS 2022.
Abbott Logo

Follow Abbott

Copyright © 2024 Abbott, 3200 Lakeside Dr, Santa Clara, 95054, U.S.A.
Caution: These products are intended for use by or under the direction of a physician. Prior to use, reference the Instructions for Use, inside the product carton (when available) or at eifu.abbottvascular.com or at medical.abbott/manuals for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.
Illustrations are artist’s representations only and should not be considered as engineering drawings or photographs. Photos on file at Abbott.
Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates.
No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

MAT-2000631 v17.0 | Item approved for OUS use only.

YOU ARE ABOUT TO ENTER AN ABBOTT COUNTRY OR REGION SPECIFIC WEBSITE.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of the product that are not approved in other countries or regions.

U.S. Health Care Professionals International Health Care Professionals

YOU ARE ABOUT TO LEAVE
www.structural­heart.abbott

You are now leaving www.structuralheart.abbott. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

OkCancel
+